Correlation Between IShares Biotechnology and Simplify Exchange

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both IShares Biotechnology and Simplify Exchange at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares Biotechnology and Simplify Exchange into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between iShares Biotechnology ETF and Simplify Exchange Traded, you can compare the effects of market volatilities on IShares Biotechnology and Simplify Exchange and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares Biotechnology with a short position of Simplify Exchange. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares Biotechnology and Simplify Exchange.

Diversification Opportunities for IShares Biotechnology and Simplify Exchange

0.85
  Correlation Coefficient

Very poor diversification

The 3 months correlation between IShares and Simplify is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding iShares Biotechnology ETF and Simplify Exchange Traded in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Simplify Exchange Traded and IShares Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iShares Biotechnology ETF are associated (or correlated) with Simplify Exchange. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Simplify Exchange Traded has no effect on the direction of IShares Biotechnology i.e., IShares Biotechnology and Simplify Exchange go up and down completely randomly.

Pair Corralation between IShares Biotechnology and Simplify Exchange

Considering the 90-day investment horizon iShares Biotechnology ETF is expected to under-perform the Simplify Exchange. In addition to that, IShares Biotechnology is 1.2 times more volatile than Simplify Exchange Traded. It trades about -0.05 of its total potential returns per unit of risk. Simplify Exchange Traded is currently generating about -0.04 per unit of volatility. If you would invest  3,303  in Simplify Exchange Traded on August 30, 2024 and sell it today you would lose (95.00) from holding Simplify Exchange Traded or give up 2.88% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

iShares Biotechnology ETF  vs.  Simplify Exchange Traded

 Performance 
       Timeline  
iShares Biotechnology ETF 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days iShares Biotechnology ETF has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong fundamental drivers, IShares Biotechnology is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Simplify Exchange Traded 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Simplify Exchange Traded has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Simplify Exchange is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

IShares Biotechnology and Simplify Exchange Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with IShares Biotechnology and Simplify Exchange

The main advantage of trading using opposite IShares Biotechnology and Simplify Exchange positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares Biotechnology position performs unexpectedly, Simplify Exchange can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Simplify Exchange will offset losses from the drop in Simplify Exchange's long position.
The idea behind iShares Biotechnology ETF and Simplify Exchange Traded pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies